io Festuccia

Molecular Cancer apeutics linical Development l Targeting of CDK and Tropomyosin Receptor Kinase ilies by the Oral Inhibitor PHA-848125 , an Agent Ther Broad-Spectrum Antitumor Efficacy

A. Isacchi, C. Mercurio, F. Colotta, 2010 .